Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that four abstracts related to the voxelotor program in sickle cell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE